EdgarLookup

Lineage Cell Therapeutics, Inc. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-K405 10-K405/A 10-Q 10-Q/A 10KSB 10QSB 144 25-NSE 3 3/A 4 4/A 424B1 424B3 424B5 425 5 5/A 8-A12B 8-A12G 8-K 8-K/A ARS AW CERTNYS CORRESP CT ORDER D D/A DEF 14A DEFA14A DEFR14A DEL AM DFAN14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRER14A REGDEX RW S-2 S-2/A S-3 S-3/A S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K BIOTIME, INC. 8-K 0001157523-17-002593 Sep 26, 2017
CT ORDER 9999999997-17-008558 Sep 12, 2017
8-K 0001493152-17-010428 Sep 11, 2017 Sep 7, 2017
4 FORM 4 SUBMISSION 0001209191-17-050305 Aug 25, 2017 Aug 23, 2017
4 OWNERSHIP DOCUMENT 0000919574-17-006374 Aug 24, 2017 Aug 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-050000 Aug 23, 2017 Aug 21, 2017
4 FORM 4 SUBMISSION 0001209191-17-050016 Aug 23, 2017 Aug 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-049877 Aug 22, 2017 Aug 21, 2017
4 FORM 4 SUBMISSION 0001209191-17-049882 Aug 22, 2017 Aug 21, 2017
4 FORM 4 SUBMISSION 0001209191-17-049764 Aug 21, 2017 Aug 17, 2017
8-K 0001493152-17-009519 Aug 17, 2017
8-K/A 0001493152-17-009296 Aug 14, 2017 Jun 29, 2017
10-Q 10-Q 0001140361-17-030912 Aug 9, 2017 Jun 30, 2017
8-K BIOTIME INC. 8-K 0001157523-17-002254 Aug 2, 2017
4 FORM 4 SUBMISSION 0001209191-17-047197 Aug 2, 2017 Jul 31, 2017
4 OWNERSHIP DOCUMENT 0000919574-17-005711 Aug 2, 2017 Jul 31, 2017
DEFR14A 0001493152-17-007791 Jul 13, 2017
4 FORM 4 SUBMISSION 0001209191-17-044959 Jul 12, 2017 Jul 10, 2017
4 FORM 4 SUBMISSION 0001209191-17-044963 Jul 12, 2017 Jul 10, 2017
S-8 0001493152-17-007613 Jul 7, 2017
8-K 0001493152-17-007542 Jul 6, 2017 Jun 29, 2017
4 FORM 4 SUBMISSION 0001209191-17-043813 Jul 5, 2017 Jul 1, 2017
4 FORM 4 SUBMISSION 0001209191-17-043821 Jul 5, 2017 Jul 1, 2017
4 BROADWOOD/BTX 0000919574-17-005170 Jul 5, 2017 Jul 1, 2017
4 FORM 4 SUBMISSION 0001209191-17-043769 Jul 5, 2017 Jul 1, 2017
4 FORM 4 SUBMISSION 0001209191-17-043772 Jul 5, 2017 Jul 1, 2017
4 FORM 4 SUBMISSION 0001209191-17-043774 Jul 5, 2017 Jul 1, 2017
4 FORM 4 SUBMISSION 0001209191-17-043781 Jul 5, 2017 Jul 1, 2017
PRER14A 0001493152-17-007417 Jun 30, 2017
DEFA14A 0001493152-17-007405 Jun 30, 2017
8-K 0001493152-17-007305 Jun 29, 2017 Jun 28, 2017
8-K 0001493152-17-007306 Jun 29, 2017
EFFECT 9999999995-17-001687 Jun 28, 2017
CORRESP 0001140361-17-026146 Jun 27, 2017
UPLOAD 0000000000-17-021930 Jun 22, 2017
4 FORM 4 SUBMISSION 0001209191-17-041267 Jun 21, 2017 Jun 16, 2017
8-K 8-K 0001140361-17-025385 Jun 16, 2017 Jun 15, 2017
S-3 S-3 0001140361-17-025384 Jun 16, 2017
8-K BIOTIME, INC. 8-K 0001157523-17-001782 Jun 14, 2017
8-K 0001493152-17-006338 Jun 8, 2017 Jun 6, 2017
4 FORM 4 SUBMISSION 0001209191-17-038596 Jun 8, 2017 Jun 6, 2017
4 FORM 4 SUBMISSION 0001209191-17-038605 Jun 8, 2017 Jun 6, 2017
4 FORM 4 SUBMISSION 0001209191-17-033460 May 17, 2017 May 16, 2017
8-K BIOTIME, INC. 8-K 0001157523-17-001525 May 10, 2017
10-Q 10-Q 0001140361-17-019338 May 10, 2017 Mar 31, 2017
EFFECT 9999999995-17-001199 May 5, 2017
DEFA14A 0001493152-17-004666 May 3, 2017
CORRESP 0001140361-17-018242 May 3, 2017
S-3/A S-3/A 0001140361-17-017943 May 2, 2017
CORRESP 0001140361-17-017938 May 2, 2017